milrinone has been researched along with Edema, Pulmonary in 15 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Milrinone significantly reduced the 1-week mortality of enterovirus 71-induced pulmonary edema and/or neurogenic shock without adverse effects." | 9.17 | Milrinone therapy for enterovirus 71-induced pulmonary edema and/or neurogenic shock in children: a randomized controlled trial. ( Chang, CM; Chi, CY; Hung, NT; Khanh, TH; Lin, CC; Liu, CC; Su, IJ; Thinh, le Q; Thoa, le PK; Thuong, TC; Tseng, FC; Wang, JR; Wang, SM; Wu, HC, 2013) |
| "The effects of oral milrinone treatment in cardiomyopathic hamsters with severe congestive heart failure (CHF) were evaluated." | 7.67 | Effects of milrinone treatment in cardiomyopathic hamsters (CHF 147) with severe congestive heart failure. ( Cauchy, MJ; Desjardins, S; Hubert, RS; Mueller, RW, 1989) |
| "Cardiogenic pulmonary edema is a frequent cause of respiratory failure." | 6.71 | Milrinone improves lung compliance in patients receiving mechanical ventilation for cardiogenic pulmonary edema. ( Ikezaki, H; Kim, C; Matsumura, J; Nakanishi, K; Ogawa, R; Sakamoto, A; Sato, N; Takeda, S; Tanaka, K, 2003) |
| "Brain-stem encephalitis and pulmonary edema are severe complications that can lead to death." | 6.71 | Therapeutic efficacy of milrinone in the management of enterovirus 71-induced pulmonary edema. ( Chen, CT; Huang, MC; Lei, HY; Liu, CC; Wang, JN; Wang, JR; Wang, SM; Wu, JM, 2005) |
| "Milrinone was administered as an intravenous infusion (0." | 5.34 | Inhalation of the phosphodiesterase-3 inhibitor milrinone attenuates pulmonary hypertension in a rat model of congestive heart failure. ( Habbazettl, H; Hentschel, T; Koster, A; Kuebler, WM; Kuppe, H; Riad, A; Tschope, C; Weimann, J; Yin, N, 2007) |
| "Milrinone significantly reduced the 1-week mortality of enterovirus 71-induced pulmonary edema and/or neurogenic shock without adverse effects." | 5.17 | Milrinone therapy for enterovirus 71-induced pulmonary edema and/or neurogenic shock in children: a randomized controlled trial. ( Chang, CM; Chi, CY; Hung, NT; Khanh, TH; Lin, CC; Liu, CC; Su, IJ; Thinh, le Q; Thoa, le PK; Thuong, TC; Tseng, FC; Wang, JR; Wang, SM; Wu, HC, 2013) |
| "The effects of oral milrinone treatment in cardiomyopathic hamsters with severe congestive heart failure (CHF) were evaluated." | 3.67 | Effects of milrinone treatment in cardiomyopathic hamsters (CHF 147) with severe congestive heart failure. ( Cauchy, MJ; Desjardins, S; Hubert, RS; Mueller, RW, 1989) |
| "Hence they alleviate pulmonary edema and suggest beneficial effects of milrinone in PH due to left heart disease." | 2.79 | Milrinone relaxes pulmonary veins in guinea pigs and humans. ( Braunschweig, T; Martin, C; Perez-Bouza, A; Rieg, AD; Rossaint, R; Schälte, G; Schröder, T; Spillner, JW; Suleiman, S; Uhlig, S; Verjans, E, 2014) |
| "Cardiogenic pulmonary edema is a frequent cause of respiratory failure." | 2.71 | Milrinone improves lung compliance in patients receiving mechanical ventilation for cardiogenic pulmonary edema. ( Ikezaki, H; Kim, C; Matsumura, J; Nakanishi, K; Ogawa, R; Sakamoto, A; Sato, N; Takeda, S; Tanaka, K, 2003) |
| "Brain-stem encephalitis and pulmonary edema are severe complications that can lead to death." | 2.71 | Therapeutic efficacy of milrinone in the management of enterovirus 71-induced pulmonary edema. ( Chen, CT; Huang, MC; Lei, HY; Liu, CC; Wang, JN; Wang, JR; Wang, SM; Wu, JM, 2005) |
| "Milrinone was initiated if LVO was < 200 mL/kg/min 1 h after surgery, to prevent PLCS." | 1.72 | Lung ultrasound score parallels trends in systemic haemodynamics after PDA ligation: a case series. ( Cattarossi, L; McNamara, PJ; Savoia, M; Titolo, A, 2022) |
| "The pulmonary edema is the result of increased pulmonary vascular permeability caused by the direct brainstem lesions and/or a systemic inflammatory response syndrome produced by the release of cytokines and chemokines." | 1.35 | Enterovirus 71: epidemiology, pathogenesis and management. ( Liu, CC; Wang, SM, 2009) |
| "Milrinone was administered as an intravenous infusion (0." | 1.34 | Inhalation of the phosphodiesterase-3 inhibitor milrinone attenuates pulmonary hypertension in a rat model of congestive heart failure. ( Habbazettl, H; Hentschel, T; Koster, A; Kuebler, WM; Kuppe, H; Riad, A; Tschope, C; Weimann, J; Yin, N, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Savoia, M | 1 |
| McNamara, PJ | 1 |
| Titolo, A | 1 |
| Cattarossi, L | 1 |
| Chi, CY | 2 |
| Khanh, TH | 1 |
| Thoa, le PK | 1 |
| Tseng, FC | 1 |
| Wang, SM | 4 |
| Thinh, le Q | 1 |
| Lin, CC | 1 |
| Wu, HC | 1 |
| Wang, JR | 2 |
| Hung, NT | 1 |
| Thuong, TC | 1 |
| Chang, CM | 1 |
| Su, IJ | 1 |
| Liu, CC | 4 |
| Nadel, S | 1 |
| Meyer, S | 1 |
| Rieg, AD | 1 |
| Suleiman, S | 1 |
| Perez-Bouza, A | 1 |
| Braunschweig, T | 1 |
| Spillner, JW | 1 |
| Schröder, T | 1 |
| Verjans, E | 1 |
| Schälte, G | 1 |
| Rossaint, R | 1 |
| Uhlig, S | 1 |
| Martin, C | 1 |
| Berger, J | 1 |
| Chabot, J | 1 |
| Pun, S | 1 |
| Pelletier, JP | 1 |
| Vautour, L | 1 |
| Giannetti, N | 1 |
| Xiong, XY | 1 |
| Liu, CF | 1 |
| Wang, LJ | 1 |
| Li, JJ | 1 |
| Xu, W | 1 |
| Wen, GF | 1 |
| Song, WL | 1 |
| Wang, YJ | 1 |
| Takeda, S | 1 |
| Matsumura, J | 1 |
| Ikezaki, H | 1 |
| Kim, C | 1 |
| Sato, N | 1 |
| Nakanishi, K | 1 |
| Sakamoto, A | 1 |
| Ogawa, R | 1 |
| Tanaka, K | 1 |
| Sethi, R | 1 |
| Tempe, DK | 1 |
| Ganjoo, P | 1 |
| Lei, HY | 1 |
| Huang, MC | 1 |
| Wu, JM | 1 |
| Chen, CT | 1 |
| Wang, JN | 1 |
| Hentschel, T | 1 |
| Yin, N | 1 |
| Riad, A | 1 |
| Habbazettl, H | 1 |
| Weimann, J | 1 |
| Koster, A | 1 |
| Tschope, C | 1 |
| Kuppe, H | 1 |
| Kuebler, WM | 1 |
| Tanaka, H | 1 |
| Tajimi, K | 1 |
| Kobayashi, K | 1 |
| Desjardins, S | 1 |
| Mueller, RW | 1 |
| Hubert, RS | 1 |
| Cauchy, MJ | 1 |
4 trials available for milrinone and Edema, Pulmonary
| Article | Year |
|---|---|
Milrinone therapy for enterovirus 71-induced pulmonary edema and/or neurogenic shock in children: a randomized controlled trial.
Topics: Cardiotonic Agents; Child, Preschool; Dobutamine; Dopamine; Enterovirus Infections; Female; Humans; | 2013 |
Milrinone relaxes pulmonary veins in guinea pigs and humans.
Topics: Animals; Female; Guinea Pigs; Humans; Large-Conductance Calcium-Activated Potassium Channels; Male; | 2014 |
Milrinone improves lung compliance in patients receiving mechanical ventilation for cardiogenic pulmonary edema.
Topics: Aged; Blood Gas Analysis; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Lung | 2003 |
Therapeutic efficacy of milrinone in the management of enterovirus 71-induced pulmonary edema.
Topics: Biomarkers; Blood Cell Count; Body Temperature; Enterovirus Infections; Female; Humans; Infant; Inte | 2005 |
11 other studies available for milrinone and Edema, Pulmonary
| Article | Year |
|---|---|
Lung ultrasound score parallels trends in systemic haemodynamics after PDA ligation: a case series.
Topics: Adult; Birth Weight; Ductus Arteriosus, Patent; Hemodynamics; Humans; Infant; Infant, Newborn; Infan | 2022 |
Hand, foot, mouth, brainstem, and heart disease resulting from enterovirus 71.
Topics: Cardiotonic Agents; Enterovirus Infections; Female; Humans; Male; Milrinone; Pulmonary Edema; Shock | 2013 |
Milrinone: some (medicolegal) thoughts beyond contractility, lusitropy, and cardiac output.
Topics: Cardiotonic Agents; Enterovirus Infections; Female; Humans; Male; Milrinone; Pulmonary Edema; Shock | 2013 |
The authors reply.
Topics: Cardiotonic Agents; Enterovirus Infections; Female; Humans; Male; Milrinone; Pulmonary Edema; Shock | 2013 |
An unexpected post-partum fulminant heart failure.
Topics: Adrenal Gland Neoplasms; Adult; Cardiotonic Agents; Catecholamines; Echocardiography; Female; Heart | 2014 |
Enterovirus 71: epidemiology, pathogenesis and management.
Topics: Adult; Brain Stem; Child; Child, Preschool; Disease Management; Encephalitis, Viral; Enterovirus A, | 2009 |
[Characteristics of circulatory disturbance and the treatment of severe hand-foot-and-mouth disease].
Topics: Child, Preschool; China; Combined Modality Therapy; Female; Hand, Foot and Mouth Disease; Humans; Im | 2012 |
Milrinone improves lung compliance.
Topics: Aged; Female; Heart Failure; Hemodynamics; Humans; Lung Compliance; Male; Middle Aged; Milrinone; Pu | 2004 |
Inhalation of the phosphodiesterase-3 inhibitor milrinone attenuates pulmonary hypertension in a rat model of congestive heart failure.
Topics: Administration, Inhalation; Animals; Cyclic AMP; Cyclic GMP; Disease Models, Animal; Dose-Response R | 2007 |
Milrinone improves arterial oxygenation in dogs with acute lung injury induced by oleic acid.
Topics: Animals; Cardiac Output; Dogs; Extravascular Lung Water; Hemodynamics; Milrinone; Oleic Acid; Oxygen | 1999 |
Effects of milrinone treatment in cardiomyopathic hamsters (CHF 147) with severe congestive heart failure.
Topics: Animals; Body Weight; Calcium; Cardiomyopathy, Dilated; Cardiotonic Agents; Cricetinae; Disease Mode | 1989 |